Nasal NK/T cell lymphoma in Taiwan: A clinicopathologic study of 22 cases, with analysis of histologic subtypes, epstein-barr virus LMP-1 gene association, and treatment modalities

International Journal of Surgical Pathology

Volumn 12, Issue 4, 2004, Pages 375-387

  Kuo, Tseng Tong ^a,b   Shih, Lee Yung ^a   Tsang, Ngan Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

30 base pair deleted LMP 1 gene; EBER in situ hybridization; Epstein Barr virus; Histologic subtypes; Nasal NK T cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; LATENT MEMBRANE PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; EPITHELIUM HYPERPLASIA; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENOMIC IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IRRADIATION; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MALE; NASAL BIOPSY; NATURAL KILLER CELL; NOSE CANCER; NOSE OBSTRUCTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; T CELL LYMPHOMA; TAIWAN; VIRUS GENE;

ADULT; AGED; FEMALE; GENE DELETION; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NOSE NEOPLASMS; RNA, VIRAL; SURVIVAL RATE; TAIWAN; VIRAL MATRIX PROTEINS;

EID: 7744223744     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200410     Document Type: Article

References (41)

1. Kassel SH, Echevarria RA, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 23:920-935, 1969
2. Strickler JG, Menses MF, Habermann TM, et al. Polymorphic reticulosis: A reappraisal. Hum Pathol 25:659-665, 1994
3. Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus (comment). Histopathology 27:581-583, 1995
4. Jaffe ES, Chan JKC, Su I-J, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103-111, 1996
5. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC Press, Lyon, pp. 204-207, 2001
6. Kanavaros P, Lescs M-C, Briere J, et al. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688-2695, 1993
7. Chiang AKS, Chan ACL, Srivastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 73:332-338, 1997
8. Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501-4513, 1997
9. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. J Clin Oncol 19:2179-2188, 2001
10. Elenitoba-Johnson KSJ, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11:754-761, 1998
11. Quintanilla-Martinez L, Franklin JL, Guerrero I, et al. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression. Hum Pathol 30:849-855, 1999
12. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 18:938-946, 1994
13. Wang D, Leibowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840, 1985
14. Chen M-L, Tsai C-N, Liang C-L, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140, 1992
15. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780, 1990
16. Hu L-F, Chen F, Zheng X, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP1. Oncogene 8:1575-1583, 1993
17. Kulwichit W, Edwards RH, Davenport EM, et al. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 95:11963-11968, 1998
18. Li S-N, Chang Y-S, Liu S-T. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135, 1996
19. Knecht H, Bachmann E, Brousset P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942, 1993
20. Sandvej K, Peh S-C, Andersen BS, et al. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060, 1994
21. Kingma DW, Weiss WB, Jaffe ES, et al. Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242-251, 1996
22. Khanim F, Yao Q-Y, Niedobitek G, et al. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-501, 1996
23. Hayashi K, Chen W-G, Chen Y-Y, et al. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion. Hum Pathol 28:1408-1414, 1997
24. Leung SY, Yuen ST, Chung LP, et al. Prevalence of mutations and 30-bp deletion in the c-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 72:225-230, 1997
25. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 30:781-787, 1999
26. Kuo, T-t, Tsang N-M. Salivary gland-type nasopharyngeal carcinoma. A histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma. Am J Surg Pathol 25:80-86, 2001
27. van Gorp J, de Bruin PC, Sie-go DMDS, et al. Nasal T-cell lymphoma: A clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 27:139-148, 1995
28. Nakamura S, Katoh E, Koshikawa T, et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int 47:38-53, 1997
29. Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70-77, 1998
30. Ferry JA, Sklar J, Zukerberg LA, et al. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 15:268-279, 1991
31. Takeshita M, Yamamoto M, Kikuchi M, et al. Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol 113:201-211, 2000
32. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 90:4099-4105, 1997
33. Victoria LV, Hoffman HT, Robinson RA. Granular cell tumor of the larynx. J Laryngol Otol 112:373-376, 1998
34. Dorji T, Cavazza A, Nappi O, et al. Spitz nevus of the tongue with pseudoepitheliomatous hyperplasia. Report of three cases of a pseudomalignant condition. Am J Surg Pathol 26:774-777, 2002
35. Krasne DL, Warnke RA, Weiss LM. Malignant lymphoma presenting as pseudoepitheliomatous hyperplasia. A report of two cases. Am J Surg Pathol 12:835-842, 1988
36. ∈ in CD3 (Leu4)-negative nasal T-cell lymphomas. Leukemia 9:44-52, 1995
37. ∈+. Blood 87:839-841, 1996
38. Tsang WYW, Chan JKC, Ng CS, et al. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 20:202-210, 1996
39. Felgar RE, Macon WR, Kinney MC, et al. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 150:1893-1900, 1997
40. Suzumiya J, Ohshima K, Takeshita M, et al. Nasal lymphomas in Japan: A high prevalence of Epstein-Barr virus type A and deletion within the latent protein gene. Leuk Lymph 35:567-578, 1999
41. Yu J-S, Tsai HC, Wu C-C, et al. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP-1-mediated transformation. Oncogene 21:8047-8061, 2002